STELLA PHARMA CORPORATION

Treatment results of unresectable, locally recurrent or locally advanced head and neck cancer published

A paper containing the treatment results of unresectable, locally recurrent or locally advanced head and neck cancer at the Kansai BNCT Medical Center of Osaka Medical and Pharmaceutical University were published in the oncology journal “Cancer Medicine”. The article’s title is “Preliminary outcomes of boron neutron capture therapy for head and neck cancers as a treatment covered by public health insurance system in Japan: Real-world experiences over a 2-year period”.

The complete article can be found following this link.

Exit mobile version